Article Data

  • Views 1993
  • Dowloads 187

Original Research

Open Access

USP15 alleviates the cerulein-induced cell apoptosis and inflammatory injury to AR42J cells through regulating TAB2/3/NF-κB pathway in acute pancreatitis

  • Yanping Zeng1
  • Weixing Ma1
  • Cheng Ma1
  • Xiaohui Ren1
  • Yan Wang1
  • Zhaoyuan Fu2

1Department of ICU, Shaoxing Central Hospital Medical Alliance General Hospital, 312030 Shaoxing, Zhejiang, China

2Department of Gastroenterology, Affiliated Hospital of Gansu University of Traditional Chinese Medicine, 730000 Lanzhou, Gansu, China

DOI: 10.22514/sv.2021.142 Vol.17,Issue 5,September 2021 pp.130-136

Submitted: 18 June 2021 Accepted: 29 July 2021

Published: 08 September 2021

*Corresponding Author(s): Zhaoyuan Fu E-mail:


Acute pancreatitis, characterized by parenchymal cell death and inflammatory process of pancreas, is a lethal disease. USP15 (ubiquitin-specific peptidase 15) belongs to USP family and participates in the ubiquitination system. USP15 was implicated in inflammatory processes and involved in the tumor progression. However, the roles of USP15 in acute pancreatitis-associated inflammation and apoptosis have not been reported yet. Firstly, in vitro cell model of acute pancreatitis was established through incubation of AR42J with cerulein. Results showed that cerulein induced inflammatory response in AR42J with up-regulation of TNF-α, IL-6 and IL-1β. USP15 was up-regulated in cerulein-induced AR42J. Secondly, siRNA-mediated silence of USP15 reduced levels of TNF-α, IL-6 and IL-1β, and pcDNA-mediated over-expression of USP15 enhanced the levels of TNF-α, IL-6 and IL-1β. Moreover, cell apoptosis of cerulein-induced AR42J was suppressed by silence of USP15 with reduced cleaved caspase-3 and cleaved caspase-9, while promoted by USP15 over-expression. Lastly, silence of USP15 decreased protein expression of p65 phosphorylation and TAB (Transforming growth factor-β activated kinase-1 binding protein) 2/3 in cerulein-induced AR42J, while the protein expression was enhanced by USP15 over-expression. In conclusion, USP15 contributed to cerulein-induced AR42J inflammatory response and cells injury through regulation of TAB2/3/NF-κB pathway in acute pancreatitis.


USP15; Cerulein; Apoptosis; Inflammatory; AR42J; TAB2/3/NF-κB; Acute pancreatitis

Cite and Share

Yanping Zeng,Weixing Ma,Cheng Ma,Xiaohui Ren,Yan Wang,Zhaoyuan Fu. USP15 alleviates the cerulein-induced cell apoptosis and inflammatory injury to AR42J cells through regulating TAB2/3/NF-κB pathway in acute pancreatitis. Signa Vitae. 2021. 17(5);130-136.


[1] Wu BU, Banks PA. Clinical Management of Patients With Acute Pancreatitis. Gastroenterology. 2013; 144: 1272–1281.

[2] Jakkampudi A, Jangala R, Reddy R, Reddy B, Venkat Rao G, Pradeep R, et al. Fatty acid ethyl ester (FAEE) associated acute pancreatitis: an ex-vivo study using human pancreatic acini. Pancreatology. 2020; 20: 1620–1630.

[3] Chen P, Huang L, Zhang Y, Qiao M, Yuan Y. SiRNA-mediated PIAS1 silencing promotes inflammatory response and leads to injury of cerulein-stimulated pancreatic acinar cells via regulation of the P38MAPK signaling pathway. International Journal of Molecular Medicine. 2010; 26: 619–626.

[4] Gómez-Cambronero LG, Sabater L, Pereda J, Cassinello N, Camps B, Viña J, et al. Role of cytokines and oxidative stress in the pathophysiology of acute pancreatitis: therapeutical implications. Current Drug Targets. Inflammation and Allergy. 2002; 1: 393–403.

[5] Wang N, Ma J, Ren Y, Xiang S, Jia R. Secreted klotho from exosomes alleviates inflammation and apoptosis in acute pancreatitis. American Journal of Translational Research. 2019; 11: 3375–3383.

[6] Hanpude P, Bhattacharya S, Dey AK, Maiti TK. Deubiquitinating enzymes in cellular signaling and disease regulation. IUBMB Life. 2015; 67: 544–555.

[7] Das T, Song EJ, Kim EE. The Multifaceted Roles of USP15 in Signal Transduction. International Journal of Molecular Sciences. 2021; 22: 4728.

[8] Georges A, Gros P, Fodil N. USP15: a review of its implication in immune and inflammatory processes and tumor progression. Genes & Immunity. 2021; 22: 12–23.

[9] Torre S, Polyak MJ, Langlais D, Fodil N, Kennedy JM, Radovanovic I, et al. USP15 regulates type i interferon response and is required for pathogenesis of neuroinflammation. Nature Immunology. 2017; 18: 54–63.

[10] Zou Q, Jin J, Hu H, Li HS, Romano S, Xiao Y, et al. USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses. Nature Immunology. 2014; 15: 562–570.

[11] Jiang B, Zhou L, Lu J, Wang Y, Liu C, Liang Z, et al. Clinicopathological and prognostic significance of ubiquitin‐specific peptidase 15 and its relationship with transforming growth factor‐β receptors in patients with pancreatic ductal adenocarcinoma. Journal of Gastroenterology and Hepatology. 2021; 36: 507–515.

[12] Bhattacharya S, Katlinski KV, Reichert M, Takano S, Brice A, Zhao B, et al. Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury. EMBO Molecular Medicine. 2014; 6: 384–397.

[13] Gao Y, Lecker S, Post MJ, Hietaranta AJ, Li J, Volk R, et al. Inhibition of ubiquitin-proteasome pathway-mediated i kappa B alpha degradation by a naturally occurring antibacterial peptide. The Journal of Clinical Investigation. 2000; 106: 439–448.

[14] Yuan T, Yan F, Ying M, Cao J, He Q, Zhu H, et al. Inhibition of Ubiquitin-Specific Proteases as a Novel Anticancer Therapeutic Strategy. Frontiers in Pharmacology. 2018; 9: 1080.

[15] Yuan J, Ma D, Liu J, Zhang L. Potent small molecule inhibitors of autophagy, and methods of use thereof. U.S. Patent Application 13/382,572[P]. 11 October 2012.

[16] Lee J, Seo J, Kim H, Chung JB, Kim KH. Signal transduction of cerulein-induced cytokine expression and apoptosis in pancreatic acinar cells. Annals of the New York Academy of Sciences. 2003; 1010: 104–108.

[17] Chen L, Smith MD, Lv L, Nakagawa T, Li Z, Sun S, et al. USP15 suppresses tumor immunity via deubiquitylation and inactivation of TET2. Science Advances. 2020; 6: eabc9730.

[18] Zhang H, Wang D, Zhong H, Luo R, Shang M, Liu D, et al. Ubiquitin-specific Protease 15 Negatively Regulates Virus-induced Type i Interferon Signaling via Catalytically-dependent and -independent Mechanisms. Scientific Reports. 2015; 5: 11220.

[19] Zhao Z, Zhang Y, Sun Y, Zhang C, Liu M. Protective effects of baicalin on caerulein-induced AR42J pancreatic acinar cells by attenuating oxidative stress through miR-136-5p downregulation. Science Progress. 2021; 104: 003685042110261.

[20] Villeneuve NF, Tian W, Wu T, Sun Z, Lau A, Chapman E, et al. USP15 negatively regulates Nrf2 through deubiquitination of Keap1. Molecular Cell. 2013; 51: 68–79.

[21] Chen X, Bao G, Liu F. Inhibition of USP15 Prevent Glutamate-Induced Oxidative Damage by Activating Nrf2HO-1 Signaling Pathway in HT22 Cells. Cellular and Molecular Neurobiology. 2020; 40: 999–1010.

[22] Xia X, Huang C, Liao Y, Liu Y, He J, Shao Z, et al. The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression. Cell Death & Disease. 2021; 12: 329.

[23] Zhou L, Jiang H, Du J, Li L, Li R, Lu J, et al. USP15 inhibits multiple myeloma cell apoptosis through activating a feedback loop with the transcription factor NF-κBp65. Experimental & Molecular Medicine. 2018; 50: 1–12.

[24] Jin G, Klika A, Callahan M, Faga B, Danzig J, Jiang Z, et al. Identification of a human NF-kappaB-activating protein, TAB3. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101: 2028–2033.

[25] Huang LGHZHSY. TAB3 overexpression promotes NF-κB activation and inflammation in acute pancreatitis. American Journal of Blood Research. 2020; 10: 118–123.

[26] Zhou Q, Cheng C, Wei Y, Yang J, Zhou W, Song Q, et al. USP15 potentiates NF-κB activation by differentially stabilizing TAB2 and TAB3. The FEBS Journal. 2020; 287: 3165–3183.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time